{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:03:38Z","timestamp":1794258218840,"version":"4.9.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15152-2","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T09:20:17Z","timestamp":1760779217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Curcumin in prostate cancer: a systematic review of molecular mechanisms and nanoformulated therapeutic strategies"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8860-7699","authenticated-orcid":false,"given":"Mojtaba","family":"Esmaeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8298-4975","authenticated-orcid":false,"given":"Maryam","family":"Dehghanpour Dehabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"issue":"1","key":"15152_CR1","first-page":"7","volume":"72","author":"R Siegel","year":"2022","unstructured":"Siegel R, Miller K, Fuchs H, Jemal A. Cancer statistics (2022). CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"15152_CR2","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1158\/1078-0432.CCR-08-2660","volume":"15","author":"KE Knudsen","year":"2009","unstructured":"Knudsen KE, Scher HI. Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer. Clin Cancer Res. 2009;15(15):4792\u20138.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"15152_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","volume":"41","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40\u201359.","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"15152_CR4","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/molecules20022728","volume":"20","author":"MK Shanmugam","year":"2015","unstructured":"Shanmugam MK, Rane G, Kanchi MM, Arfuso F, Chinnathambi A, Zayed M, et al. The multifaceted role of curcumin in cancer prevention and treatment. Molecules. 2015;20(2):2728\u201369.","journal-title":"Molecules"},{"issue":"15","key":"15152_CR5","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1042\/CS20160935","volume":"131","author":"AB Kunnumakkara","year":"2017","unstructured":"Kunnumakkara AB, Bordoloi D, Harsha C, Banik K, Gupta SC, Aggarwal BB. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. Clin Sci (Lond). 2017;131(15):1781\u201399. https:\/\/doi.org\/10.1042\/CS20160935.","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"15152_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biom10111536","volume":"10","author":"D Termini","year":"2020","unstructured":"Termini D, Den Hartogh DJ, Jaglanian A, Tsiani E. Curcumin against prostate cancer: current evidence. Biomolecules. 2020;10(11):1536.","journal-title":"Biomolecules"},{"issue":"6","key":"15152_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807\u201318.","journal-title":"Mol Pharm"},{"issue":"3","key":"15152_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11030322","volume":"11","author":"Y Hussain","year":"2022","unstructured":"Hussain Y, Alam W, Ullah H, Dacrema M, Daglia M, Khan H, et al. Antimicrobial potential of curcumin: therapeutic potential and challenges to clinical applications. Antibiotics. 2022;11(3):322.","journal-title":"Antibiotics"},{"issue":"1","key":"15152_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4143\/crt.2014.46.1.2","volume":"46","author":"S Prasad","year":"2014","unstructured":"Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat. 2014;46(1):2\u201318.","journal-title":"Cancer Res Treat"},{"issue":"1\u20132","key":"15152_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.drudis.2011.09.009","volume":"17","author":"MM Yallapu","year":"2012","unstructured":"Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today. 2012;17(1\u20132):71\u201380.","journal-title":"Drug Discov Today"},{"key":"15152_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s13577-020-00337-7","volume":"33","author":"MA De Velasco","year":"2020","unstructured":"De Velasco MA, Lu Y, Kura Y, China T, Inoue Y, Nakayama A, et al. Chemopreventive effects of nanoparticle curcumin in a mouse model of Pten-deficient prostate cancer. Hum Cell. 2020;33:730\u20136.","journal-title":"Hum Cell"},{"key":"15152_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110181","volume":"127","author":"Y Chen","year":"2020","unstructured":"Chen Y, Deng Y, Zhu C, Xiang C. Anti prostate cancer therapy: aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles. Biomed Pharmacother. 2020;127:110181.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"15152_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/10717544.2022.2048133","volume":"29","author":"MW Al-Rabia","year":"2022","unstructured":"Al-Rabia MW, Alhakamy NA, Rizg WY, Alghaith AF, Ahmed OA, Fahmy UA. Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles. Drug Deliv. 2022;29(1):807\u201320.","journal-title":"Drug Deliv"},{"issue":"3","key":"15152_CR14","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.21873\/invivo.12396","volume":"35","author":"A Nakayama","year":"2021","unstructured":"Nakayama A, Ide H, Lu Y, Takei A, Fukuda K, Osaka A, et al. Effects of curcumin combined with the 5-alpha reductase inhibitor dutasteride on LNCaP prostate cancer cells. in vivo. 2021;35(3):1443\u201350.","journal-title":"in vivo"},{"issue":"1","key":"15152_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8859181","volume":"2021","author":"Y-J Lee","year":"2021","unstructured":"Lee Y-J, Park K-S, Lee S-H. Curcumin targets both apoptosis and necroptosis in acidity-tolerant prostate carcinoma cells. BioMed Res Int. 2021;2021(1):8859181.","journal-title":"BioMed Res Int"},{"issue":"13","key":"15152_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137013","volume":"22","author":"E Bevacqua","year":"2021","unstructured":"Bevacqua E, Curcio M, Saletta F, Vittorio O, Cirillo G, Tucci P. Dextran-curcumin nanosystems inhibit cell growth and migration regulating the epithelial to mesenchymal transition in prostate cancer cells. Int J Mol Sci. 2021;22(13):7013.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"15152_CR17","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10401","volume":"22","author":"L Pan","year":"2021","unstructured":"Pan L, Sha J, Lin W, Wang Y, Bian T, Guo J. Curcumin inhibits prostate cancer progression by regulating the miR-30a-5p\/PCLAF axis. Exp Ther Med. 2021;22(3):969.","journal-title":"Exp Ther Med"},{"issue":"1","key":"15152_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11033-025-10448-9","volume":"52","author":"G Tossetta","year":"2025","unstructured":"Tossetta G, Fantone S, Busilacchi EM, Marzioni D, Mazzucchelli R. Dose-dependent effects of curcumin on 22Rv1 prostate cancer cell line. Mol Biol Rep. 2025;52(1):1\u201310.","journal-title":"Mol Biol Rep"},{"issue":"18","key":"15152_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189966","volume":"22","author":"J Rutz","year":"2021","unstructured":"Rutz J, Benchellal A, Kassabra W, Maxeiner S, Bernd A, Kippenberger S, et al. Growth, proliferation and metastasis of prostate cancer cells is blocked by low-dose curcumin in combination with light irradiation. Int J Mol Sci. 2021;22(18):9966.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"15152_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25122737","volume":"25","author":"S Mapoung","year":"2020","unstructured":"Mapoung S, Suzuki S, Fuji S, Naiki-Ito A, Kato H, Yodkeeree S, et al. Dehydrozingerone, a curcumin analog, as a potential anti-prostate cancer inhibitor in vitro and in vivo. Molecules. 2020;25(12):2737.","journal-title":"Molecules"},{"key":"15152_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150477","volume":"735","author":"M Pellegrino","year":"2024","unstructured":"Pellegrino M, Occhiuzzi MA, Grande F, Pagani IS, Aquaro S, Tucci P. Modulation of energetic and lipid pathways by curcumin as a potential chemopreventive strategy in human prostate cancer cells. Biochem Biophys Res Commun. 2024;735:150477.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"15152_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-98102-z","volume":"15","author":"J Yakubu","year":"2025","unstructured":"Yakubu J, Natsaridis E, du Toit T, Barata IS, Tagit O, Pandey AV. Nanoparticles with curcumin and piperine modulate steroid biosynthesis in prostate cancer. Sci Rep. 2025;15(1):13613.","journal-title":"Sci Rep"},{"key":"15152_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143348","volume":"14","author":"M Boccellino","year":"2022","unstructured":"Boccellino M, Ambrosio P, Ballini A, De Vito D, Scacco S, Cantore S, et al. The role of curcumin in prostate cancer cells and derived spheroids. Cancers (Basel). 2022;14:3348.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"15152_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11072023","volume":"11","author":"M Pellegrino","year":"2023","unstructured":"Pellegrino M, Bevacqua E, Frattaruolo L, Cappello AR, Aquaro S, Tucci P. Enhancing the anticancer and anti-inflammatory properties of curcumin in combination with quercetin, for the prevention and treatment of prostate cancer. Biomedicines. 2023;11(7):2023.","journal-title":"Biomedicines"},{"issue":"10","key":"15152_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10101591","volume":"10","author":"S Ossikbayeva","year":"2021","unstructured":"Ossikbayeva S, Khanin M, Sharoni Y, Trachtenberg A, Tuleukhanov S, Sensenig R, et al. Curcumin and carnosic acid cooperate to inhibit proliferation and alter mitochondrial function of metastatic prostate cancer cells. Antioxidants. 2021;10(10):1591.","journal-title":"Antioxidants"},{"key":"15152_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1039\/c9pp00375d","volume":"19","author":"K Kazantzis","year":"2020","unstructured":"Kazantzis K, Koutsonikoli K, Mavroidi B, Zachariadis M, Alexiou P, Pelecanou M, et al. Curcumin derivatives as photosensitizers in photodynamic therapy: photophysical properties and in vitro studies with prostate cancer cells. Photochemical & Photobiological Sciences. 2020;19:193\u2013206.","journal-title":"Photochemical & Photobiological Sciences."},{"key":"15152_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00637","volume":"11","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Yang Y, Wu Y, Wang W, Xiao L, Zhang Y, et al. The curcumin derivative, H10, suppresses hormone-dependent prostate cancer by inhibiting 17\u03b2-hydroxysteroid dehydrogenase type 3. Front Pharmacol. 2020;11:637.","journal-title":"Front Pharmacol"},{"issue":"23","key":"15152_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192316193","volume":"19","author":"E Costantini","year":"2022","unstructured":"Costantini E, Di Nicola M, Marchioni M, Aielli L, Reale M, Schips L. Effects of curcumin and lactoferrin to inhibit the growth and migration of prostatic cancer cells. Int J Environ Res Public Health. 2022;19(23):16193.","journal-title":"Int J Environ Res Public Health"},{"issue":"21","key":"15152_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27217410","volume":"27","author":"MAI Alhasawi","year":"2022","unstructured":"Alhasawi MAI, Aatif M, Muteeb G, Alam MW, Oirdi ME, Farhan M. Curcumin and its derivatives induce apoptosis in human cancer cells by mobilizing and redox cycling genomic copper ions. Molecules. 2022;27(21):7410.","journal-title":"Molecules"},{"issue":"15","key":"15152_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28155719","volume":"28","author":"P Wo\u017aniak","year":"2023","unstructured":"Wo\u017aniak P, Kleczka A, Jasik K, Kaba\u0142a-Dzik A, Dzik R, Stojko J. The effect of natural substances contained in bee products on prostate cancer in in vitro studies. Molecules. 2023;28(15):5719.","journal-title":"Molecules"},{"issue":"4","key":"15152_CR31","first-page":"429","volume":"13","author":"R Panahizadeh","year":"2023","unstructured":"Panahizadeh R, Vatankhah MA, Jeddi F, Arabzadeh A, Nejati-Koshki K, Salimnejad R, et al. Cytotoxicity of curcumin against CD44\u00b1prostate cancer cells: Roles of miR-383 and miR-708. Avicenna journal of phytomedicine. 2023;13(4):429.","journal-title":"Avicenna journal of phytomedicine."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15152-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15152-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15152-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:01:56Z","timestamp":1760824916000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15152-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,18]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15152"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15152-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,18]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1609"}}